Showing results (1311-1320 of 3,182) with videos related to

Sort By:
Pageof 319
Translational Oncology|December 11, 2025
Comparative prognostic value of preoperative SII, NLR, and MLR and their association with TNM staging in gallbladder cancer: A multicenter retrospective studyZhenhao Huang, Jing Luo, Jintong He, et al.
Translational Oncology|December 2, 2025
From benchside avatars to bedside breakthroughs: Patient-derived organoids in the new era of cancer immunotherapyZhihui Mi, Hui Guan, Guodong Zhang, et al.
Translational Oncology|November 30, 2025
Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancerEirini Papadopoulou, Elena Fountzilas, Vasiliki Metaxa-Mariatou, et al.
Translational Oncology|November 30, 2025
The prognostic value of tumor macroscopic morphology in colorectal cancerHsinyi Lin, Zimin Zhao, Yao Ma, et al.
Translational Oncology|December 22, 2024
Beyond first-line therapy: efficacy and safety outcomes of continuing immunotherapy in extensive stage small cell lung cancer after PD-L1 inhibitor progressionJianfeng Peng, Xueying Zhai, Xiaomei Liu, et al.
Translational Oncology|December 22, 2024
EMC2 suppresses ferroptosis via regulating TFRC in nasopharyngeal carcinomaXianghui Chen, Xiaoyan Wang, Yuxia Zou, et al.
Translational Oncology|December 16, 2024
Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis inductionStéphanie Verbeke, Aurélien Bourdon, Mathilde Lafon, et al.
Translational Oncology|December 29, 2024
circICMT upregulates and suppresses the malignant behavior of bladder cancerXin Luo, FangMei Xie, Guoqiang Qin, et al.
Translational Oncology|December 29, 2024
LPCAT3 regulates the proliferation and metastasis of serous ovarian cancer by modulating arachidonic acidFang Wen, Hongjian Ling, Rui Ran, et al.
Translational Oncology|February 8, 2025
Currents status of radiotracers for breast cancer imaging in PETChloé Jean, Stéphane Roux, Abdelilah Aziz, et al.
Pageof 319